Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial idiopathic steroid-resistant nephrotic syndrome is characterized by a nephrotic syndrome with often early onset.
Biomarker and diagnostic research for familial idiopathic steroid-resistant nephrotic syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
9 clinical trials registered, 5 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT02194582](https://clinicaltrials.gov/study/NCT02194582) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 12:16 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure
— |
Beth Israel Deaconess Medical Center |
ACTIVE_NOT_RECRUITING |
[NCT06443034](https://clinicaltrials.gov/study/NCT06443034) | Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1 | — | Assistance Publique - Hôpitaux de Paris | UNKNOWN |
[NCT01605266](https://clinicaltrials.gov/study/NCT01605266) | INSIGHT (Insight Into Nephrotic Syndrome) | — | The Hospital for Sick Children | RECRUITING |
[NCT06635720](https://clinicaltrials.gov/study/NCT06635720) | REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE) | PHASE3 | The Hospital for Sick Children | ACTIVE_NOT_RECRUITING |
[NCT06315504](https://clinicaltrials.gov/study/NCT06315504) | Circulating Factors in Nephrotic Syndrome | — | Iain Bressendorff | NOT_YET_RECRUITING |
24 publications have been identified in PubMed for familial idiopathic steroid-resistant nephrotic syndrome. Research spans Epidemiology / Natural History (38%), Basic Science / Preclinical (21%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 9 | 38% |
Laboratory research | 5 | 21% |
Research summaries | 4 | 17% |
Patient case studies | 4 | 17% |
Testing and diagnosis research | 1 | 4% |
New treatment approaches | 1 | 4% |
Wei B (2026). [PMID: 41782252](https://pubmed.ncbi.nlm.nih.gov/41782252/). *Ophthalmic Genet*. [Case Report / Case Series]
Wongboonsin J (2026). [PMID: 41453490](https://pubmed.ncbi.nlm.nih.gov/41453490/). *Kidney Int*. [Basic Science / Preclinical]
Lal K (2026). [PMID: 41824887](https://pubmed.ncbi.nlm.nih.gov/41824887/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Terkawi R (2026). [PMID: 41966991](https://pubmed.ncbi.nlm.nih.gov/41966991/). *J Nephrol*. [Case Report / Case Series]
Hammad AM (2026). [PMID: 41914989](https://pubmed.ncbi.nlm.nih.gov/41914989/). *Saudi J Kidney Dis Transpl*. [Epidemiology / Natural History]
Román Ortiz E (2026). [PMID: 41361594](https://pubmed.ncbi.nlm.nih.gov/41361594/). *Pediatr Nephrol*. [Case Report / Case Series]
Ozimek A (2026). [PMID: 41517577](https://pubmed.ncbi.nlm.nih.gov/41517577/). *J Clin Med*. [Epidemiology / Natural History]
Finnie J (2026). [PMID: 41087043](https://pubmed.ncbi.nlm.nih.gov/41087043/). *Arch Dis Child*. [Epidemiology / Natural History]
Bahans C (2026). [PMID: 41933842](https://pubmed.ncbi.nlm.nih.gov/41933842/). *J Clin Epidemiol*. [Epidemiology / Natural History]
Mühlig AK (2026). [PMID: 42026266](https://pubmed.ncbi.nlm.nih.gov/42026266/). *Pediatr Nephrol*. [Review / Meta-Analysis]